Challenges in the translation and commercialization of cell therapies

被引：0
作者：
Brittany P. Dodson
Aaron D. Levine
机构：
[1] Georgia Institute of Technology,School of Public Policy
[2] Parker H. Petit Institute for Bioengineering and Bioscience,School of Public Policy
[3] Georgia Institute of Technology,undefined
来源：
BMC Biotechnology | / 15卷
关键词：
Cell Therapy; Chimeric Antigen Receptor; Product History; Cell Therapy Product; Provenge;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cell therapies for Chagas disease
    Carvalho, Adriana Bastos
    Dos Santos Goldenberg, Regina Coeli
    Campos de Carvalho, Antonio Carlos
    CYTOTHERAPY, 2017, 19 (11) : 1339 - 1349
  • [42] Stem cell therapies in the clinic
    Acharya, Shrinivas
    Shaha, Suyog
    Bibbey, Michael Griffith
    Mukherji, Malini
    Zhao, Zongmin
    Mitragotri, Samir
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2025,
  • [43] Process evolution in cell and gene therapy from discovery to commercialization
    Csaszar, Elizabeth
    Mills, Sara
    Zandstra, Peter W.
    CANADIAN JOURNAL OF CHEMICAL ENGINEERING, 2021, 99 (11) : 2517 - 2524
  • [44] Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach
    Krackhardt, Angela M.
    Anliker, Brigitte
    Hildebrandt, Martin
    Bachmann, Michael
    Eichmueller, Stefan B.
    Nettelbeck, Dirk M.
    Renner, Matthias
    Uharek, Lutz
    Willimsky, Gerald
    Schmitt, Michael
    Wels, Winfried S.
    Schuessler-Lenz, Martina
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (04) : 513 - 523
  • [45] Advanced Cell Therapies for Glioblastoma
    Wang, Guangwen
    Wang, Wenshi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Strategies for More Rapid Translation of Cellular Therapies for Children: A US Perspective
    Sanchez, Rosa
    Silberstein, Leslie E.
    Lindblad, Robert W.
    Welniak, Lisbeth A.
    Mondoro, Heath
    Wagner, John E.
    PEDIATRICS, 2013, 132 (02) : 351 - 358
  • [47] Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer's disease: progress, advantages, and challenges
    de Jesus Goncalves, Renata Guedes
    Vasques, Juliana Ferreira
    da Silva-Junior, Almir Jordao
    Gubert, Fernanda
    Mendez-Otero, Rosalia
    NEURAL REGENERATION RESEARCH, 2023, 18 (08) : 1645 - 1651
  • [48] Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges
    Zhou, Lindsay
    McDonald, Courtney
    Yawno, Tamara
    Jenkin, Graham
    Miller, Suzanne
    Malhotra, Atul
    STEM CELLS TRANSLATIONAL MEDICINE, 2022, 11 (02) : 135 - 145
  • [49] Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts
    Zheng, Ping-Pin
    Kros, Johan M.
    Li, Jin
    DRUG DISCOVERY TODAY, 2018, 23 (06) : 1175 - 1182
  • [50] Adenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies
    Boison, Detlev
    EPILEPSY RESEARCH, 2009, 85 (2-3) : 131 - 141
12345